Theodorus

Theodorus is the venture capital arm of Université Libre de Bruxelles in Belgium, focusing on seed, early-stage, and start-up investments exclusively in spin-offs from the university. The firm specializes in sectors such as biotechnology, medical devices, engineering technologies, and high tech. It primarily invests in the Walloon region of Belgium, providing funding that ranges from 0.25 million € to 2 million € per company. Theodorus operates from its headquarters in Brussels, Belgium, and maintains an additional office in Montreal, Canada, where it supports projects that utilize proprietary disruptive technologies.

Olivier Belenger

Managing Partner

Adrien Van der Borght

Investment Manager

Marie Bouillez

Managing Partner

Lotfi Yelles Chaouche

Partner

Patricia Escoffier

Investment Manager

Alexandre Jouve

Investment Manager

Théo Risopoulos

Investment Manager

Past deals in Belgium

Cascador Health

Seed Round in 2022
Cascador Health operates a healthcare data platform designed to connect data providers with the research industry. The platform provides access to structured, validated, and anonymized real-world data, enabling healthcare providers and life science clients to gain valuable insights. This data assists in understanding therapeutic outcomes, improving site selection for clinical studies, monitoring safety and adverse effects, and optimizing hospital processes. By facilitating access to comprehensive data, Cascador Health aims to enhance healthcare delivery and support better patient care.

Kaspard

Series A in 2021
Kaspard is a Belgian company founded in 2017 that specializes in developing a non-intrusive sensory system aimed at enhancing the safety and well-being of elderly individuals in residential societies and nursing homes. The system is designed to monitor risk-related movements, such as when a patient gets out of bed or experiences a fall, while respecting their privacy. Kaspard's technology includes a small, contactless detection device that provides timely information and raises alarms at various levels, enabling staff to respond quickly and effectively to incidents involving residents. By improving monitoring capabilities, Kaspard seeks to enhance the quality of care for elderly individuals, ultimately contributing to better health outcomes in care facilities.

ChromaCure

Venture Round in 2018
ChromaCure will launch a drug development program to identify potential new candidates that selectively and potently inhibit cancer targets and potentially provide novel therapy for multiple forms of cancer, either as monotherapy or in combination with immunotherapy or chemotherapy.

Virteo NV

Series A in 2018
Virteo NV, founded in 2013 and headquartered in Mechelen, Belgium, operates a SaaS-based platform designed to recover unpaid invoices. The platform facilitates both internal dunning and external debt collection processes, catering to a diverse clientele that includes corporations, small and medium-sized enterprises, public institutions, court bailiffs, and lawyers. By providing tools that enable credit managers to collaborate directly with external partners, such as lawyers and recovery agencies, Virteo enhances efficiency and transparency in the debt collection process. The company emphasizes a socially responsible approach, allowing creditors to enforce ethical practices while achieving economic goals. Through its platform, Virteo empowers clients to reduce costs, improve recovery results, and maintain oversight of their external collection partners, fostering a more compliant and responsible debt recovery environment.

PharmaFluidics

Venture Round in 2018
Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.

Acar'Up

Venture Round in 2017
AllerInvest develops and design a trap device designed to extract and kill the allergenic dust mites living in mattresses, chairs, carpets and other upholstered furniture.

X4C

Seed Round in 2016
Monolayer chemical coating technology

Domobios

Seed Round in 2016
Domobios S.A., founded in 2013 and based in Brussels, Belgium, focuses on developing, manufacturing, and selling products aimed at eradicating domestic pests, particularly allergenic dust mites. The company is known for its innovative Acar’up device, which effectively extracts and kills dust mites from various household items such as mattresses, chairs, and carpets. In addition to the Acar’up, Domobios produces sprays and technical textiles designed to attract and capture these pests. Its products are available through pharmacies, medical supply stores, and online platforms, catering to both the Belgian market and international customers.

Domobios

Seed Round in 2015
Domobios S.A., founded in 2013 and based in Brussels, Belgium, focuses on developing, manufacturing, and selling products aimed at eradicating domestic pests, particularly allergenic dust mites. The company is known for its innovative Acar’up device, which effectively extracts and kills dust mites from various household items such as mattresses, chairs, and carpets. In addition to the Acar’up, Domobios produces sprays and technical textiles designed to attract and capture these pests. Its products are available through pharmacies, medical supply stores, and online platforms, catering to both the Belgian market and international customers.

Ovizio

Venture Round in 2015
Ovizio Imaging Systems NV/SA specializes in the development of digital holographic interferometric microscopy products, creating advanced 4D microscopic imaging devices and software. Founded in 2009 and headquartered in Brussels, Belgium, the company offers a range of devices, including the oLine 4D, which requires no specific sample preparation and compensates for sample imperfections; the iLine 4D, designed for various applications such as flow monitoring and cell culture observation; and various specialized instruments like ILine F for real-time monitoring of suspension cell cultures and iLine M for assessing cell confluence in multi-layer vessels. Ovizio also provides OsOne software for the visualization, analysis, and archiving of captured images, alongside QMod, which integrates holographic and fluorescence microscopy. Its products are widely utilized by scientists in pharmaceutical and biotechnology research and development, facilitating advancements in automated cell culture monitoring and analysis.

CluePoints

Series A in 2015
CluePoints INC designs and develops cloud-based risk-based quality management and monitoring software. The company offers its solutions to pharmaceutical companies and contract research organizations (CROs) to identify, visualize, manage, and document risks. The company was incorporated in 2012 and is based in King of Prussia, Pennsylvania. It has an additional office in Louvain-la-Neuve, Belgium.

neoScores

Series A in 2015
neoScores is a pioneer in offering digital music scores. It gives musicians the opportunity to simply and securely purchase scores or to use and to share notes with fellow musicians, anywhere they are. Gustaf is an OS and device independent web platform that allows the distribution of digital sheet music. High in quality, easy and flexible, beautiful and stylish, Gustaf allows to use scores via smartphone, tablet or computer through any operating system. That is how neoScores® wants to change the way sheet music is used by musicians. neoScores® was founded in July 2013 by Bart Van der Roost, Bob Hamblok and Jonas Coomans, three professional musicians with a passion for new media.

PharmaFluidics

Venture Round in 2014
Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.